β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis | Zendy

Chaoran Li | Zendy; Li Tian | Zendy; Runwei Tang | Zendy; Shuai Yuan | Zendy; Weihong Zhang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis

Author(s) -

Chaoran Li,

Li Tian,

Runwei Tang,

Shuai Yuan,

Weihong Zhang

Publication year - 2020

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20200721

Subject(s) - medicine , breast cancer , observational study , relative risk , confidence interval , meta analysis , subgroup analysis , cochrane library , cancer , oncology , gynecology , retrospective cohort study , prospective cohort study , obstetrics

Evidence remains inconsistent regarding the potential influence of β-blocker (BB) use on clinical outcomes in women with breast cancer. We aimed to evaluate the association between BB and prognosis of breast cancer in an updated meta-analysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research